Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$37.8 - $45.97 $1.27 Million - $1.55 Million
-33,635 Closed
0 $0
Q2 2023

Nov 13, 2023

SELL
$37.95 - $58.98 $62,921 - $97,788
-1,658 Reduced 4.7%
33,635 $1.38 Million
Q2 2023

Aug 10, 2023

SELL
$37.95 - $58.98 $62,921 - $97,788
-1,658 Reduced 4.7%
33,635 $1.38 Million
Q1 2023

Nov 13, 2023

BUY
$52.61 - $60.49 $45,928 - $52,807
873 Added 2.54%
35,293 $2.03 Million
Q1 2023

May 16, 2023

BUY
$52.61 - $60.49 $45,928 - $52,807
873 Added 2.54%
35,293 $2.03 Million
Q4 2022

Nov 13, 2023

BUY
$42.17 - $58.6 $33,103 - $46,001
785 Added 2.33%
34,420 $1.93 Million
Q4 2022

Feb 03, 2023

SELL
$42.17 - $58.6 $156,619 - $217,640
-3,714 Reduced 9.74%
34,420 $1.93 Million
Q3 2022

Oct 26, 2022

SELL
$42.28 - $57.17 $10,231 - $13,835
-242 Reduced 0.63%
38,134 $1.62 Million
Q2 2022

Aug 08, 2022

SELL
$53.86 - $66.52 $20,466 - $25,277
-380 Reduced 0.98%
38,376 $2.07 Million
Q1 2022

May 12, 2022

BUY
$62.86 - $69.24 $244,902 - $269,759
3,896 Added 11.18%
38,756 $2.49 Million
Q4 2021

Jan 25, 2022

SELL
$62.47 - $73.25 $30,235 - $35,453
-484 Reduced 1.37%
34,860 $2.34 Million
Q3 2021

Nov 04, 2021

BUY
$64.97 - $76.19 $34,693 - $40,685
534 Added 1.53%
35,344 $2.42 Million
Q2 2021

Aug 09, 2021

BUY
$66.79 - $76.63 $1.27 Million - $1.45 Million
18,944 Added 119.4%
34,810 $2.38 Million
Q1 2021

May 14, 2021

SELL
$62.63 - $71.15 $14,467 - $16,435
-231 Reduced 1.44%
15,866 $1.1 Million
Q4 2020

Feb 09, 2021

SELL
$43.31 - $66.55 $17,713 - $27,218
-409 Reduced 2.48%
16,097 $1.04 Million
Q3 2020

Nov 05, 2020

SELL
$43.33 - $51.72 $15,555 - $18,567
-359 Reduced 2.13%
16,506 $779,000
Q2 2020

Jul 30, 2020

BUY
$41.42 - $55.57 $698,548 - $937,188
16,865 New
16,865 $793,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.